Healthy Returns: New FDA rules affect copycat GLP-1s, and Apple adds health tools to its latest Watch (2025-09-10)
The FDA took a step to crack down on compounded GLP-1s, but it's not exactly a win for Novo Nordisk and Eli Lilly. Meanwhile,